Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Grandaliano, G.
Right arrow Articles by Schena, F. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Grandaliano, G.
Right arrow Articles by Schena, F. P.
J Am Soc Nephrol 14:2072-2083, 2003
© 2003 American Society of Nephrology

Protease-Activated Receptor-2 Expression in IgA Nephropathy: A Potential Role in the Pathogenesis of Interstitial Fibrosis

Giuseppe Grandaliano*, Paola Pontrelli*, Giuseppina Cerullo*, Raffaella Monno*, Elena Ranieri*, Michele Ursi*, Antonella Loverre*, Loreto Gesualdo{dagger} and Francesco P. Schena*

*Division of Nephrology, Department of Emergency and Transplantation, University of Bari, Policlinico, Bari; and {dagger}Chair of Nephrology, University of Foggia, Italy.

Correspondence to Dr. Giuseppe Grandaliano, Division of Nephrology, Department of Emergency and Transplantation, University of Bari, Policlinico, Piazza G. Cesare 11, 70124, Bari, Italy. Phone: +39-080-5592787; Fax: +39-080-5593227;

ABSTRACT. An increasing body of evidence suggests that proteases may play a key role in the pathogenesis of tissue fibrosis. Protease-activated receptor-2 (PAR-2) is cleaved and activated by trypsin-like proteolytic enzymes, including tryptase and activated coagulation factor X (FXa). Both these soluble mediators have been demonstrated, directly or indirectly, at the interstitial level in progressive renal diseases, including IgA nephropathy (IgAN). PAR-2 mRNA and protein levels were investigated by RT-PCR and immunohistochemistry, respectively, in 17 biopsies from IgAN patients and 10 normal kidneys. PAR-2 expression was also evaluated, by RT-PCR and western blotting, in cultured human mesangial and proximal tubular cells. Finally, gene expression of plasminogen activator inhibitor-1 (PAI-1) and TGF-{beta}, two powerful fibrogenic factors, was evaluated in FXa-, trypsin-, and PAR-2 activating peptide-stimulated human proximal tubular cells by Northern blot. In normal kidneys, PAR-2 gene expression was barely detectable, whereas in IgAN biopsies the mRNA levels for this protease receptor were strikingly increased and directly correlated with the extent of interstitial fibrosis. Immunohistochemical staining demonstrated that PAR-2 protein expression in IgAN biopsies was mainly localized in the proximal tubuli and within the interstitial infiltrate. Proximal tubular cells in culture expressed PAR-2. Activation of this receptor by FXa in tubular cells induced a striking increase in intracellular calcium concentration. In addition, incubation of both cell lines with trypsin, FXa, or PAR-2 activating peptide caused a marked upregulation of PAI-1 gene expression that was not counterbalanced by an increased expression of plasminogen activators. Finally, PAR-2 activation induced a significant upregulation of TGF-{beta} gene and protein expression in both mesangial and tubular cells. On the basis of our data, we can suggest that PAR-2 expressed by renal resident cells and activated by either mast cell tryptase or FXa may induce extracellular matrix deposition modifying the PAI-1/PA balance and inducing TGF-{beta} expression. These molecular mechanisms may underlie interstitial fibrosis in IgAN. E-mail: g.grandaliano@nephro.uniba.it




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
L. Morla, G. Crambert, D. Mordasini, G. Favre, A. Doucet, and M. Imbert-Teboul
Proteinase-activated Receptor 2 Stimulates Na,K-ATPase and Sodium Reabsorption in Native Kidney Epithelium
J. Biol. Chem., October 17, 2008; 283(42): 28020 - 28028.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
K. Borensztajn, J. Stiekema, S. Nijmeijer, P. H. Reitsma, M. P. Peppelenbosch, and C. A. Spek
Factor Xa Stimulates Proinflammatory and Profibrotic Responses in Fibroblasts via Protease-Activated Receptor-2 Activation
Am. J. Pathol., February 1, 2008; 172(2): 309 - 320.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
D. A. Vesey, W. A. Kruger, P. Poronnik, G. C. Gobe, and D. W. Johnson
Proinflammatory and proliferative responses of human proximal tubule cells to PAR-2 activation
Am J Physiol Renal Physiol, November 1, 2007; 293(5): F1441 - F1449.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
L. Moussa, J. Apostolopoulos, P. Davenport, J. Tchongue, and P. G. Tipping
Protease-Activated Receptor-2 Augments Experimental Crescentic Glomerulonephritis
Am. J. Pathol., September 1, 2007; 171(3): 800 - 808.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
P. Pontrelli, M. Ursi, E. Ranieri, C. Capobianco, F. P. Schena, L. Gesualdo, and G. Grandaliano
CD40L Proinflammatory and Profibrotic Effects on Proximal Tubular Epithelial Cells: Role of NF-{kappa}B and Lyn
J. Am. Soc. Nephrol., March 1, 2006; 17(3): 627 - 636.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
A. Loverre, P. Ditonno, A. Crovace, L. Gesualdo, E. Ranieri, P. Pontrelli, G. Stallone, B. Infante, A. Schena, S. Di Paolo, et al.
Ischemia-Reperfusion Induces Glomerular and Tubular Activation of Proinflammatory and Antiapoptotic Pathways: Differential Modulation by Rapamycin
J. Am. Soc. Nephrol., October 1, 2004; 15(10): 2675 - 2686.
[Abstract] [Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP